Crossmark

Comment on “The efficiency of risedronate in reducing bone resorption after total hip arthroplasty: a meta-analysis of randomized control trials at a minimum of 6 months’ follow-up”

Crossref DOI link: https://doi.org/10.1186/s13018-022-03118-0

Published Online: 2022-04-12

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kai Huang, M. M.

Gang Wang, M. M.

Yi Zeng, M. D. https://orcid.org/0000-0003-1650-8020
License Information

Text and Data Mining valid from 2022-04-12

Version of Record valid from 2022-04-12
More Information

Article History

Received: 20 February 2022

Accepted: 27 February 2022

First Online: 12 April 2022

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below